Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|10 Apr 2018||Submitted||Original manuscript|
|16 Apr 2018||Author responded||Author comments - Ines Stevic|
|Resubmission - Version 2|
|16 Apr 2018||Submitted||Manuscript version 2|
|18 May 2018||Reviewed||Reviewer Report - Carolyn Klinge|
|11 Jul 2018||Reviewed||Reviewer Report - César López-Camarillo|
|14 Aug 2018||Author responded||Author comments - Ines Stevic|
|Resubmission - Version 3|
|14 Aug 2018||Submitted||Manuscript version 3|
|15 Aug 2018||Reviewed||Reviewer Report - Carolyn Klinge|
|27 Aug 2018||Reviewed||Reviewer Report - César López-Camarillo|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|30 Aug 2018||Editorially accepted|
|10 Oct 2018||Article published||10.1186/s12916-018-1163-y|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.